LU93259I2 - LETIFEND (Protein Q) - Google Patents
LETIFEND (Protein Q) Download PDFInfo
- Publication number
- LU93259I2 LU93259I2 LU93259C LU93259C LU93259I2 LU 93259 I2 LU93259 I2 LU 93259I2 LU 93259 C LU93259 C LU 93259C LU 93259 C LU93259 C LU 93259C LU 93259 I2 LU93259 I2 LU 93259I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- protein
- letifend
- pharmaceutical composition
- leishmaniasis
- proteins
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 241000222697 Leishmania infantum Species 0.000 abstract 1
- 208000004554 Leishmaniasis Diseases 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11382598P | 1998-12-23 | 1998-12-23 | |
| CA2256124A CA2256124C (fr) | 1998-12-23 | 1998-12-23 | Gene chimere forme de sequences d'adn codant pour les sites antigeniques de quatre proteines de l. infantum, proteine codee par le gene en question et composition pharmaceutique utile pour prevenir et/ou traiter la leishmaniose chez les animaux ou les humains |
| PCT/EP1999/010441 WO2000039298A1 (fr) | 1998-12-23 | 1999-12-23 | Gene chimerique forme par les sequences d'adn codant pour les determinants antigeniques de quatre proteines de l. infantum, proteines codees par ledit gene, et compositions pharmaceutiques servant a prevenir et/ou traiter la leishmaniase chez l'animal et l'homme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU93259I2 true LU93259I2 (fr) | 2016-12-06 |
Family
ID=25680668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU93259C LU93259I2 (fr) | 1998-12-23 | 2016-10-06 | LETIFEND (Protein Q) |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1141305B1 (fr) |
| CN (1) | CN1158387C (fr) |
| AT (2) | ATE429498T1 (fr) |
| AU (1) | AU759316B2 (fr) |
| BE (1) | BE2016C049I2 (fr) |
| BG (1) | BG65569B1 (fr) |
| BR (1) | BRPI9916549B8 (fr) |
| CY (3) | CY1105331T1 (fr) |
| CZ (1) | CZ20012360A3 (fr) |
| DE (2) | DE69940793D1 (fr) |
| DK (1) | DK1141305T3 (fr) |
| ES (2) | ES2273519T3 (fr) |
| HR (1) | HRP20010554A2 (fr) |
| HU (1) | HUP0104743A3 (fr) |
| IL (2) | IL143956A0 (fr) |
| LU (1) | LU93259I2 (fr) |
| MX (1) | MXPA01006548A (fr) |
| NL (1) | NL300830I2 (fr) |
| PT (2) | PT1141305E (fr) |
| SI (1) | SI1624063T1 (fr) |
| TR (1) | TR200102655T2 (fr) |
| WO (1) | WO2000039298A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6613337B1 (en) * | 1997-02-12 | 2003-09-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| ES2169995B1 (es) * | 2000-04-17 | 2003-12-01 | Leti Lab | Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno. |
| US6673351B1 (en) | 2001-03-16 | 2004-01-06 | Astralis, Llc | Compositions and methods for the treatment and clinical remission of psoriasis |
| WO2006058243A2 (fr) * | 2004-11-24 | 2006-06-01 | Yale University | Antigenes de leishmania, compositions apparentees et utilisations correspondantes |
| RU2521499C2 (ru) * | 2008-01-18 | 2014-06-27 | Лабораториос Лети, С.Л. Униперсональ | ВАКЦИНА, СОДЕРЖАЩАЯ ЭКСТРАКТ РИБОСОМНОГО БЕЛКА (RPE) И Th1- АКТИВИРУЮЩИЙ АДЪЮВАНТ |
| BR112012000679A2 (pt) * | 2009-07-13 | 2016-11-01 | Leti Sl Lab | diagnóstico de uma doença parasitária como a leishmaniose utilizando um extrato de proteína ribossômica (epr) |
| SA110310855B1 (ar) | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي |
| BR102019003639A2 (pt) * | 2019-02-22 | 2021-11-16 | Fundação Oswaldo Cruz | Proteína quimérica, seu método para produção e uso, bem como molécula de ácido nucleico, cassete de expressão, vetor de expressão, célula hospedeira, composição para diagnóstico de leishmaniose, kit de diagnóstico de leishmaniose e método de diagnóstico de leishmaniose in vitro |
| ES2795149B2 (es) | 2020-06-08 | 2022-07-04 | Univ Madrid Complutense | Quimera sintetica multiepitopica como vacuna y tratamiento frente a leishmaniosis en mamiferos |
| CN112662694A (zh) * | 2020-12-25 | 2021-04-16 | 康九生物科技(长春)有限公司 | 一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0703295A1 (fr) * | 1994-09-26 | 1996-03-27 | Institut Pasteur | Vaccin comprenant un BCG recombinant exprimant une protéine de fusion de GP63 |
| US5912166A (en) * | 1995-04-21 | 1999-06-15 | Corixa Corporation | Compounds and methods for diagnosis of leishmaniasis |
| ES2133236B1 (es) * | 1997-06-27 | 2000-04-16 | Leti Lab | Gen quimerico formado por las secuencias de dna que codifican los determinantes antigenicos de cuatro proteinas de l. infantum, aplicable para el diagnostico serologico de leishmaniosis canina y proteina obtenida. |
-
1999
- 1999-12-23 DE DE69940793T patent/DE69940793D1/de not_active Expired - Lifetime
- 1999-12-23 ES ES99967987T patent/ES2273519T3/es not_active Expired - Lifetime
- 1999-12-23 CZ CZ20012360A patent/CZ20012360A3/cs unknown
- 1999-12-23 AU AU24342/00A patent/AU759316B2/en not_active Expired
- 1999-12-23 SI SI9931029T patent/SI1624063T1/sl unknown
- 1999-12-23 WO PCT/EP1999/010441 patent/WO2000039298A1/fr active IP Right Grant
- 1999-12-23 CN CNB998163066A patent/CN1158387C/zh not_active Expired - Lifetime
- 1999-12-23 PT PT99967987T patent/PT1141305E/pt unknown
- 1999-12-23 IL IL14395699A patent/IL143956A0/xx unknown
- 1999-12-23 AT AT05109393T patent/ATE429498T1/de not_active IP Right Cessation
- 1999-12-23 PT PT05109393T patent/PT1624063E/pt unknown
- 1999-12-23 BR BRPI9916549A patent/BRPI9916549B8/pt not_active IP Right Cessation
- 1999-12-23 EP EP99967987A patent/EP1141305B1/fr not_active Expired - Lifetime
- 1999-12-23 AT AT99967987T patent/ATE327332T1/de active
- 1999-12-23 DE DE69931518T patent/DE69931518T2/de not_active Expired - Lifetime
- 1999-12-23 TR TR2001/02655T patent/TR200102655T2/xx unknown
- 1999-12-23 DK DK99967987T patent/DK1141305T3/da active
- 1999-12-23 ES ES05109393T patent/ES2326174T3/es not_active Expired - Lifetime
- 1999-12-23 HU HU0104743A patent/HUP0104743A3/hu unknown
- 1999-12-23 MX MXPA01006548A patent/MXPA01006548A/es active IP Right Grant
-
2001
- 2001-06-24 IL IL143956A patent/IL143956A/en not_active IP Right Cessation
- 2001-07-23 HR HR20010554A patent/HRP20010554A2/hr not_active Application Discontinuation
- 2001-07-23 BG BG105725A patent/BG65569B1/bg unknown
-
2006
- 2006-08-24 CY CY20061101190T patent/CY1105331T1/el unknown
-
2009
- 2009-07-14 CY CY20091100739T patent/CY1109221T1/el unknown
-
2016
- 2016-09-22 NL NL300830C patent/NL300830I2/nl unknown
- 2016-10-06 BE BE2016C049C patent/BE2016C049I2/nl unknown
- 2016-10-06 LU LU93259C patent/LU93259I2/fr unknown
- 2016-10-20 CY CY2016033C patent/CY2016033I1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU93259I2 (fr) | LETIFEND (Protein Q) | |
| CY1110128T1 (el) | Καταλυτικα μονοκλωνικα αντισωματα με δραστικοτητα πρωτεασης για την εκλεκτικη λυση του πρωτεϊνικου συστατικου των πλακων και συνονθυλευματων που σχετιζονται με παθολογικες καταστασεις | |
| ATE348113T1 (de) | Rekombinanter anti-cd4 antikörper zur menschlichen behandlung | |
| DK0910647T3 (da) | Human DNase i hyperaktive varianter | |
| DE60035693D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
| TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
| DE69534633D1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
| MXPA04001986A (es) | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| DE60107888D1 (de) | Beta-Interferon zur Behandlung von Immunerkrankungen | |
| MY101874A (en) | Vaccine | |
| WO2001040465A3 (fr) | Compositions et procedes de traitement de maladies d'ordre immunologique | |
| YU51601A (sh) | Himerni gen koji kodira antigene determinante četiri proteina l.infantum | |
| PL336897A1 (en) | Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts | |
| DE59410423D1 (de) | Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose | |
| EE05139B1 (et) | Peptiid, seda kodeeriv geen, reagent ja reaktiivikomplekt riketsioosi tuvastamiseks ning peptiidi sisaldav vaktsiin | |
| ATE309359T1 (de) | Epil/plazentin | |
| WO2001066740A3 (fr) | Compositions et methodes de traitement de maladies d'origine immune | |
| AU7079300A (en) | Compositions and methods for the treatment of immune related diseases | |
| ATE480560T1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen |